Ipratropium bromide use in Australia outside guidelines

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.348, 2002-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhanced fenoterol/ipratropium bromide delivery in COPD

Inpharma, Vol. 1, Iss. 1443, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Ipratropium bromide: Anisocoria in an infant: case report

Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

Ipratropium bromide/salbutamol interaction: Mydriasis: case report

Reactions Weekly, Vol. 1, Iss. 1288, 2010-01 ,pp. : 24-25

Adis International

Access to resources Recommend Favorite

Manufacture, Characterization, and Pharmacodynamic Evaluation of Engineered Ipratropium Bromide Particles

By Taylor Michael Hickey Anthony VanOort Michiel

Pharmaceutical Development and Technology, Vol. 11, Iss. 3, 2006-09 ,pp. : 321-336

Informa Healthcare

Access to resources Recommend Favorite

Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease

By Gordon Joshiah Panos Ralph J

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 381-392

Informa Healthcare

Access to resources Recommend Favorite